Contribution of traditional Chinese medicine to the treatment of COVID-19
Review
[키워드] COVID-19
COVID-19, Coronavirus disease 2019
ERK, extracellular signal-regulated kinases
FGF, fibroblast growth factor
GCSF, granulocyte-colony stimulating factor
GMCSF, Granulocyte-macrophage colony-stimulating factor
IFNγ, interferon gamma
IL, interleukin
Integrated therapy
IP10, Interferon gamma-induced protein 10
LPS, lipopolysaccharides
MAPK, Mitogen-activated protein kinase
MCP1, monocyte chemoattractant protein 1
MERS, Middle East respiratory syndrome
MIP1A, macrophage Inflammatory Protein 1 Alpha
MIP1B, macrophage Inflammatory Protein 1 beta
NF-κB, Nuclear factor kappa
NLRP3, NACHT, LRR and PYD domains-containing protein 3
PDGF, platelet-derived growth factor
SARS-COV-2, 2019 novel coronavirus
SARS, Severe acute respiratory syndrome
TCM, traditional Chinese medicine
TNF, Tumor Necrosis Factor
Traditional Chinese medicine
VEGF, Vascular endothelial growth factor
WHO, World Health Organization
[DOI] 10.1016/j.phymed.2020.153279 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.phymed.2020.153279 PMC 바로가기 [Article Type] Review